160 related articles for article (PubMed ID: 37176504)
1. Cardioselective versus Non-Cardioselective Beta-Blockers and Outcomes in Patients with Atrial Fibrillation and Chronic Obstructive Pulmonary Disease.
Vlachopoulou D; Balomenakis C; Kartas A; Samaras A; Papazoglou AS; Moysidis DV; Barmpagiannos K; Kyriakou M; Papanastasiou A; Baroutidou A; Vouloagkas I; Tzikas A; Giannakoulas G
J Clin Med; 2023 Apr; 12(9):. PubMed ID: 37176504
[No Abstract] [Full Text] [Related]
2. Rates of hospitalizations and emergency department visits in patients with asthma and chronic obstructive pulmonary disease taking beta-blockers.
Brooks TW; Creekmore FM; Young DC; Asche CV; Oberg B; Samuelson WM
Pharmacotherapy; 2007 May; 27(5):684-90. PubMed ID: 17461703
[TBL] [Abstract][Full Text] [Related]
3. Impact of chronic obstructive pulmonary disease in patients with atrial fibrillation: an analysis from the GLORIA-AF registry.
Romiti GF; Corica B; Mei DA; Frost F; Bisson A; Boriani G; Bucci T; Olshansky B; Chao TF; Huisman MV; Proietti M; Lip GYH
Europace; 2023 Dec; 26(1):. PubMed ID: 38266129
[TBL] [Abstract][Full Text] [Related]
4. Evidence of potential bias in a comparison of β blockers and calcium channel blockers in patients with chronic obstructive pulmonary disease and acute coronary syndrome: results of a multinational study.
Dong YH; Alcusky M; Maio V; Liu J; Liu M; Wu LC; Chang CH; Lai MS; Gagne JJ
BMJ Open; 2017 Mar; 7(3):e012997. PubMed ID: 28363921
[TBL] [Abstract][Full Text] [Related]
5. Use of cardioselective β-blockers and overall death and cardiovascular outcomes in patients with COPD: a population-based cohort study.
Dong YH; Chang CH; Wu LC; Lai MS
Eur J Clin Pharmacol; 2016 Oct; 72(10):1265-1273. PubMed ID: 27444174
[TBL] [Abstract][Full Text] [Related]
6. Cardioselective beta-blockers for chronic obstructive pulmonary disease.
Salpeter SS; Ormiston T; Salpeter E; Poole P; Cates C
Cochrane Database Syst Rev; 2002; (2):CD003566. PubMed ID: 12076486
[TBL] [Abstract][Full Text] [Related]
7. Impact of cardioselective beta-blockers on mortality in patients with chronic obstructive pulmonary disease and atherosclerosis.
van Gestel YR; Hoeks SE; Sin DD; Welten GM; Schouten O; Witteveen HJ; Simsek C; Stam H; Mertens FW; Bax JJ; van Domburg RT; Poldermans D
Am J Respir Crit Care Med; 2008 Oct; 178(7):695-700. PubMed ID: 18565952
[TBL] [Abstract][Full Text] [Related]
8. Impact of chronic obstructive pulmonary disease on prognosis in atrial fibrillation: A report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry.
Proietti M; Laroche C; Drozd M; Vijgen J; Cozma DC; Drozdz J; Maggioni AP; Boriani G; Lip GY;
Am Heart J; 2016 Nov; 181():83-91. PubMed ID: 27823697
[TBL] [Abstract][Full Text] [Related]
9. Cardioselective Versus Nonselective β-Blockers After Myocardial Infarction in Adults With Chronic Obstructive Pulmonary Disease.
Chung CM; Lin MS; Chang ST; Wang PC; Yang TY; Lin YS
Mayo Clin Proc; 2022 Mar; 97(3):531-546. PubMed ID: 35135688
[TBL] [Abstract][Full Text] [Related]
10. Associations of Atrial Fibrillation Patterns With Mortality and Cardiovascular Events: Implications of the MISOAC-AF Trial.
Baroutidou A; Kartas A; Samaras A; Papazoglou AS; Vrana E; Moysidis DV; Akrivos E; Papanastasiou A; Vouloagkas I; Botis M; Liampas E; Karagiannidis AG; Karagiannidis E; Efthimiadis G; Karvounis H; Tzikas A; Giannakoulas G
J Cardiovasc Pharmacol Ther; 2022; 27():10742484211069422. PubMed ID: 35006026
[TBL] [Abstract][Full Text] [Related]
11. Association of Length of Stay With the Clinical Trajectory of Hospitalized Patients With Atrial Fibrillation: Staying Less Is More?
Moura A; Baliafa E; Alexandropoulos C; Papazoglou AS; Kartas A; Samaras A; Solovou C; Kontopyrgou D; Ioannou M; Moysidis DV; Bekiaridou A; Tzikas A; Ziakas A; Giannakoulas G
Am J Cardiol; 2023 Nov; 206():254-261. PubMed ID: 37716224
[TBL] [Abstract][Full Text] [Related]
12. Association of beta-blocker use and selectivity with outcomes in patients with heart failure and chronic obstructive pulmonary disease (from OPTIMIZE-HF).
Mentz RJ; Wojdyla D; Fiuzat M; Chiswell K; Fonarow GC; O'Connor CM
Am J Cardiol; 2013 Feb; 111(4):582-7. PubMed ID: 23200803
[TBL] [Abstract][Full Text] [Related]
13. Prognostic implications of thyroid disease in patients with atrial fibrillation.
Vasilopoulou A; Patsiou V; Bekiaridou A; Papazoglou AS; Moysidis DV; Spaho M; Zergioti M; Kostakakis D; Kyriakideli ME; Lampropoulou CI; Kartas A; Samaras A; Baroutidou A; Tzikas A; Ziakas A; Giannakoulas G
Heart Vessels; 2024 Feb; 39(2):185-193. PubMed ID: 38087071
[TBL] [Abstract][Full Text] [Related]
14. Association of β-blocker use with survival and pulmonary function in patients with chronic obstructive pulmonary and cardiovascular disease: a systematic review and meta-analysis.
Yang YL; Xiang ZJ; Yang JH; Wang WJ; Xu ZC; Xiang RL
Eur Heart J; 2020 Dec; 41(46):4415-4422. PubMed ID: 33211823
[TBL] [Abstract][Full Text] [Related]
15. Cardioselective beta-blockers for chronic obstructive pulmonary disease: a meta-analysis.
Salpeter SR; Ormiston TM; Salpeter EE; Poole PJ; Cates CJ
Respir Med; 2003 Oct; 97(10):1094-101. PubMed ID: 14561016
[TBL] [Abstract][Full Text] [Related]
16. Chronic obstructive pulmonary disease and atrial fibrillation: An unknown relationship.
Goudis CA
J Cardiol; 2017 May; 69(5):699-705. PubMed ID: 28188041
[TBL] [Abstract][Full Text] [Related]
17. Effect of β-blockers on the risk of COPD exacerbations according to indication of use: the Rotterdam Study.
Karimi L; Lahousse L; De Nocker P; Stricker BH; Brusselle GG; Verhamme KMC
ERJ Open Res; 2021 Apr; 7(2):. PubMed ID: 34195251
[TBL] [Abstract][Full Text] [Related]
18. Use of cardioselective β-blockers in patients with chronic obstructive pulmonary disease: a meta-analysis of randomized, placebo-controlled, blinded trials.
Ni Y; Shi G; Wan H
J Int Med Res; 2012; 40(6):2051-65. PubMed ID: 23321161
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics and prognostic significance of chronic obstructive pulmonary disease in patients with atrial fibrillation: results from a multicenter atrial fibrillation registry study.
Huang B; Yang Y; Zhu J; Liang Y; Zhang H; Tian L; Shao X; Wang J
J Am Med Dir Assoc; 2014 Aug; 15(8):576-81. PubMed ID: 24894999
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of diabetes mellitus in patients with atrial fibrillation.
Papazoglou AS; Kartas A; Samaras A; Vouloagkas I; Vrana E; Moysidis DV; Akrivos E; Kotzampasis G; Baroutidou A; Papanastasiou A; Liampas E; Botis M; Karagiannidis E; Stalikas N; Karvounis H; Tzikas A; Giannakoulas G
Cardiovasc Diabetol; 2021 Feb; 20(1):40. PubMed ID: 33573666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
